VYNE Therapeutics Inc.
VYNE
$0.36
-$0.01-2.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 32.70M | 39.65M | 50.27M | 61.52M | 70.19M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.19M | 4.70M | 4.64M | 2.92M | 3.30M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 47.00K |
| Total Current Assets | 35.89M | 44.34M | 54.91M | 64.44M | 73.54M |
|
|
|||||
| Total Current Assets | 35.89M | 44.34M | 54.91M | 64.44M | 73.54M |
| Net Property, Plant & Equipment | 96.00K | 134.00K | 169.00K | 206.00K | 122.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 150.00K | 241.00K | 1.34M | 2.26M | 2.54M |
| Total Assets | 36.13M | 44.72M | 56.42M | 66.91M | 76.20M |
|
|
|||||
| Total Accounts Payable | 1.20M | 1.41M | 3.53M | 2.71M | 3.99M |
| Total Accrued Expenses | 2.85M | 4.40M | 5.28M | 8.59M | 7.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 25.00K | 63.00K | 99.00K | 123.00K |
| Total Finance Division Other Current Liabilities | -- | -- | 3.41M | 3.42M | 1.31M |
| Total Other Current Liabilities | -- | -- | 3.41M | 3.42M | 1.31M |
| Total Current Liabilities | 4.04M | 5.84M | 12.29M | 14.82M | 12.66M |
|
|
|||||
| Total Current Liabilities | 4.04M | 5.84M | 12.29M | 14.82M | 12.66M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.04M | 5.84M | 12.29M | 14.82M | 12.66M |
|
|
|||||
| Common Stock & APIC | 784.90M | 784.42M | 783.91M | 783.24M | 782.65M |
| Retained Earnings | -752.82M | -745.54M | -739.78M | -731.17M | -719.15M |
| Treasury Stock & Other | 4.00K | -2.00K | -- | 20.00K | 34.00K |
| Total Common Equity | 32.09M | 38.88M | 44.13M | 52.09M | 63.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 32.09M | 38.88M | 44.13M | 52.09M | 63.54M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.09M | 38.88M | 44.13M | 52.09M | 63.54M |
|
|
|||||